A novel solid-phase assembly for identifying potent and selective RNA ligands

Angewandte Chemie - International Edition

Volumn 39, Issue 10, 2000, Pages 1788-1790

  Luedtke, Nathan W ^a   Tor, Yitzhak ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analytical methods; Fluorescence spectroscopy; Glycosides; HIV; RNA recognition

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; FRAMYCETIN; KANAMYCIN A; KANAMYCIN B; LIGAND; REV PROTEIN; RNA BINDING PROTEIN; TOBRAMYCIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG POTENCY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGAND BINDING; NONHUMAN; RNA BINDING; VIRUS REPLICATION;

EID: 0034658578     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(20000515)39:10<1788::AID-ANIE1788>3.0.CO;2-6     Document Type: Article

References (29)

1. Y. N. Vaishnav, F. Wong-Staal, Annu. Rev. Biochem. 1991, 60, 577-630.
2. A. D. Frankel, J. A. T. Young, Annu. Rev. Biochem. 1998, 67, 1-25; V. W. Pollard, M. H. Malim, Annu. Rev. Microbiol. 1998, 52, 491-532; T. J. Hope, Arch. Biochem. Biophys. 1999, 365, 186-191.
3. A. D. Frankel, J. A. T. Young, Annu. Rev. Biochem. 1998, 67, 1-25; V. W. Pollard, M. H. Malim, Annu. Rev. Microbiol. 1998, 52, 491-532; T. J. Hope, Arch. Biochem. Biophys. 1999, 365, 186-191.
4. A. D. Frankel, J. A. T. Young, Annu. Rev. Biochem. 1998, 67, 1-25; V. W. Pollard, M. H. Malim, Annu. Rev. Microbiol. 1998, 52, 491-532; T. J. Hope, Arch. Biochem. Biophys. 1999, 365, 186-191.
5. M. L. Zapp, S. Stern, M. R. Green, Cell 1993, 74, 969-978.
6. S. R. Kirk, N. W. Luedtke, Y. Tor, J. Am. Chem. Soc. 2000, 122, 980-981.
7. Y. Tor, Angew. Chem. 1999, 111. 1681-1685; Angew. Chem. Int. Ed. 1999, 38, 1579-1582.
8. Y. Tor, Angew. Chem. 1999, 111. 1681-1685; Angew. Chem. Int. Ed. 1999, 38, 1579-1582.
9. For other modulators of the Rev-RRE interaction, see W. K. C. Park, M. Auer, H. Jaksche, C.-H. Wong, J. Am. Chem. Soc. 1996, 118, 10150-10155; M. L. Zapp, D. W. Young, A. Kumar, R. Singh, D. W. Boykin, W. D. Wilson, M. R. Green, Bioorg. Med. Chem. 1997, 5, 1149-1155.
10. For other modulators of the Rev-RRE interaction, see W. K. C. Park, M. Auer, H. Jaksche, C.-H. Wong, J. Am. Chem. Soc. 1996, 118, 10150-10155; M. L. Zapp, D. W. Young, A. Kumar, R. Singh, D. W. Boykin, W. D. Wilson, M. R. Green, Bioorg. Med. Chem. 1997, 5, 1149-1155.
11. a) M. Hendrix, E. S. Priestley, G. F. Joyce, C.-H. Wong, J. Am. Chem. Soc. 1997, 119, 3641-3648;
12. b) K. Michael, Y. Tor, Chem. Eur. J. 1998, 4, 2091-2098.
13. [7a]
14. See also: R. H. Greig, M. J. Greig, H. An. H. Sasmor, S. Manalili, J. Am. Chem. Soc. 1999, 121, 474-475; K. Hamasaki, R. R. Rando, Anal. Biochem. 1998, 261, 183-140.
15. See also: R. H. Greig, M. J. Greig, H. An. H. Sasmor, S. Manalili, J. Am. Chem. Soc. 1999, 121, 474-475; K. Hamasaki, R. R. Rando, Anal. Biochem. 1998, 261, 183-140.
16. S. M. Holland, M. Chavez, S. Gerstberger, S. Venkatesan, J. Virol. 1992, 66, 3699-3706; L. S. Tilley, M. H. Malim, H. K. Tewary, P. G. Stockley, B. R. Cullen, Proc. Natl. Acad. Sci. USA 1992, 89, 758-762.
17. S. M. Holland, M. Chavez, S. Gerstberger, S. Venkatesan, J. Virol. 1992, 66, 3699-3706; L. S. Tilley, M. H. Malim, H. K. Tewary, P. G. Stockley, B. R. Cullen, Proc. Natl. Acad. Sci. USA 1992, 89, 758-762.
18. J. Kjems, B. J. Canlan, A. D. Frankel, P. A. Sharp, EMBO J. 1992, 11,. 1119-1129.
19. [13]
20. See Supporting Information for experimental details.
21. [17] In contrast, very low concentrations of the unlabeled Rev peptide or non-biotinylated RRE (40 and 90 nM, respectively) are needed to displace 50% of Rev-Fl. These results taken together suggest a high degree of binding specificity for the immobilixed Rev-RRE complex.
22. -1 gel), which suggests that the immobilized RRE complexes are noninteracting over this loading range.
23. 50 values are reported.
24. -1 of acomplex mixture of yeast pre-tRNAs and mature tRNAs (Sigma type X). This is approximately a 50-fold molar excess of DNA nucleotides and a 200-fold molar excess of a tRNA nucleotides (relative to the RRE). These concentrations lead to a minimal (5- 10 %) displacement of the Rev-Fl from the solid support.
25. K. Li, G. Xiao, T. Rigl, A. Kumar, D.W. Boykin, W. D. Wilson, Structure, Motion, Interaction and Expression of Biological Macromolecules (Eds.: R. H. Sarma, M. H. Sarma), Adenine Press, 1998, pp. 137-145.
26. For a review on fluorescence anisotropy and its limitations, see R. F. Steiner, Topics in Fluorescence Spectroscopy, Vol. 2: Principles (Ed.: J. R. Lakowicz), Plenum, New York, 1991, pp. 1-52; see also: A. J. Pope, U M. Haupts, K. J. Moore, Drug Discovery Today 1999, 4, 350- 362.
27. For a review on fluorescence anisotropy and its limitations, see R. F. Steiner, Topics in Fluorescence Spectroscopy, Vol. 2: Principles (Ed.: J. R. Lakowicz), Plenum, New York, 1991, pp. 1-52; see also: A. J. Pope, U M. Haupts, K. J. Moore, Drug Discovery Today 1999, 4, 350-362.
28. [13]
29. For the synthesis and photophysical properties of these complexes, see A. Rudi, Y. Kashman, Y. D. Gut, E Lellouche, M. Kol, Chem. Commun. 1997, 17-18.